Lijun Xia Selected Research

epsin

1/2021	Epsins 1 and 2 promote NEMO linear ubiquitination via LUBAC to drive breast cancer development.
4/2016	Motif mimetic of epsin perturbs tumor growth and metastasis.
3/2016	Selective Targeting of a Novel Epsin-VEGFR2 Interaction Promotes VEGF-Mediated Angiogenesis.
12/2015	Motif mimetic of epsin perturbs tumor growth and metastasis.
3/2015	Epsin is required for Dishevelled stability and Wnt signalling activation in colon cancer development.
2/2014	Genetic reduction of vascular endothelial growth factor receptor 2 rescues aberrant angiogenesis caused by epsin deficiency.
12/2012	Endothelial epsin deficiency decreases tumor growth by enhancing VEGF signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lijun Xia Research Topics

Disease

19	Neoplasms (Cancer) 01/2023 - 06/2003
10	Colitis 01/2023 - 06/2007
10	Inflammation (Inflammations) 01/2022 - 03/2011
8	Neoplasm Metastasis (Metastasis) 01/2021 - 12/2013
5	Thrombosis (Thrombus) 01/2022 - 10/2011
4	Colonic Neoplasms (Colon Cancer) 01/2023 - 11/2006
4	Hemorrhage 01/2022 - 02/2004
3	Hemophilia A (Haemophilia) 01/2023 - 08/2003
3	Thrombocytopenia (Thrombopenia) 01/2022 - 01/2015
3	Sepsis (Septicemia) 11/2021 - 12/2014
3	Atherosclerosis 01/2021 - 06/2008
3	Hyperplasia 01/2018 - 09/2012
3	Colorectal Neoplasms (Colorectal Cancer) 01/2017 - 06/2007
3	Ulcerative Colitis 01/2016 - 06/2007
2	Thrombotic Thrombocytopenic Purpura 01/2022 - 01/2020
2	Atherosclerotic Plaque (Atheroma) 01/2021 - 06/2008
2	Breast Neoplasms (Breast Cancer) 01/2021 - 08/2015
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2021 - 12/2013
2	Adenocarcinoma 01/2020 - 11/2018
2	Carcinogenesis 01/2020 - 01/2016
2	Infections 01/2016 - 10/2013
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2006 - 02/2004
1	Sickle Cell Anemia (Hemoglobin S Disease) 12/2023
1	acquired Thrombotic thrombocytopenic purpura 01/2022
1	Tinnitus 12/2021
1	Aneurysm (Aneurysms) 01/2021
1	COVID-19 01/2021
1	Adenocarcinoma of Lung 01/2021
1	Glioma (Gliomas) 07/2020
1	Gastritis 01/2020
1	Liver Diseases (Liver Disease) 01/2020
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020
1	Coronary Stenosis (Coronary Artery Stenosis) 01/2020
1	Stomach Neoplasms (Stomach Cancer) 01/2020

Drug/Important Bio-Agent (IBA)

14	Polysaccharides (Glycans)IBA 01/2023 - 02/2004
10	MucinsIBA 01/2023 - 12/2008
7	epsinIBA 01/2021 - 12/2012
5	von Willebrand FactorIBA 01/2022 - 04/2016
5	Tn antigenIBA 01/2020 - 02/2004
4	Phosphotransferases (Kinase)IBA 01/2021 - 08/2008
3	LigandsIBA 01/2023 - 10/2011
3	Apolipoproteins E (ApoE)IBA 01/2021 - 06/2008
3	Glycoproteins (Glycoprotein)IBA 01/2020 - 01/2015
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2018 - 01/2016
3	CateninsIBA 01/2018 - 09/2012
3	UbiquitinIBA 03/2016 - 03/2015
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2016 - 12/2012
3	SelectinsIBA 07/2015 - 11/2004
3	P-selectin ligand proteinIBA 10/2011 - 06/2008
2	Dextrans (Dextran)FDA Link 01/2023 - 01/2014
2	LectinsIBA 01/2023 - 11/2018
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 01/2022
2	Thrombin FDA Link 01/2022 - 10/2011
2	thiamine triphosphorate (TTP)IBA 01/2022 - 01/2020
2	Monoclonal AntibodiesIBA 01/2022 - 01/2017
2	Estrogen ReceptorsIBA 01/2021 - 01/2021
2	NF-kappa B (NF-kB)IBA 01/2021 - 11/2006
2	Protein Kinases (Protein Kinase)IBA 07/2020 - 01/2017
2	CaspasesIBA 01/2020 - 01/2016
2	Proteins (Proteins, Gene)FDA Link 01/2016 - 03/2015
2	Phenobarbital (Luminal)FDA Link 01/2016 - 10/2013
2	P-SelectinIBA 12/2010 - 08/2003
2	Proteasome InhibitorsIBA 08/2008 - 11/2006
2	Proteasome Endopeptidase Complex (Proteasome)IBA 08/2008 - 11/2006
1	NucleotidesIBA 12/2023
1	GlobinsIBA 12/2023
1	Galactose (Galactopyranose)FDA LinkGeneric 01/2023
1	Galectin 3 (LGALS3)IBA 01/2023
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2023
1	Hemostatics (Antihemorrhagics)IBA 01/2023
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2023
1	GlycosyltransferasesIBA 01/2023
1	Peptide Hydrolases (Proteases)FDA Link 01/2022
1	Eptifibatide (Integrilin)FDA Link 01/2022
1	AnticoagulantsIBA 01/2022
1	Blood Coagulation Factors (Coagulation Factor)IBA 01/2022
1	CoagulantsIBA 01/2022
1	IntegrinsIBA 01/2022
1	Protein CIBA 01/2022
1	Kupffer cell receptorIBA 11/2021
1	Viral ProteinsIBA 01/2021
1	GTP-Binding Proteins (G-Protein)IBA 01/2021
1	Angiopoietin-1IBA 01/2021
1	Long Noncoding RNAIBA 01/2021
1	Circular RNAIBA 07/2020
1	InflammasomesIBA 01/2020
1	C-Type Lectins (C-Type Lectin)IBA 01/2020
1	AntigensIBA 01/2020
1	Complement Inactivating AgentsIBA 01/2020
1	Complement System Proteins (Complement)IBA 01/2020
1	Dinoprostone (PGE2)FDA Link 01/2019
1	Alcian BlueIBA 11/2018

Therapy/Procedure

4	Therapeutics 12/2021 - 11/2006
2	Punctures 01/2022 - 12/2014
2	Ligation 01/2021 - 12/2014
1	Oral Administration 01/2022
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 12/2021
1	Hyperbaric Oxygenation 12/2021
1	Transcranial Magnetic Stimulation 12/2021
1	Platelet Transfusion (Blood Platelet Transfusions) 01/2020